Rocket Pharmaceuticals, Inc

(NASDAQ:RCKT)

Latest On Rocket Pharmaceuticals, Inc (RCKT):

Date/Time Type Description Signal Details
2023-05-31 09:29 ESTNewsRocket Pharma granted priority medicines tag for Danon Disease candidate in EUN/A
2023-05-23 16:54 ESTNewsRocket's gene therapy RP-L301 for rare blood disorder gets FDA regenerative medicine tagN/A
2023-05-19 14:22 ESTNewsRocket stock rises amid data from multiple gene therapy programsN/A
2023-05-11 23:58 ESTNewsRocket Pharmaceuticals: A Catalyst-Rich Year AheadN/A
2023-05-09 17:33 ESTNewsRocket Pharma wins FDA nod to start trial for heart disease candidateN/A
2023-03-10 12:40 ESTNewsRocket Pharmaceuticals doesn't have any cash, securities at Silicon Valley BankN/A
2023-02-27 18:58 ESTNewsRocket Pharmaceuticals GAAP EPS of -$0.92 misses by $0.10N/A
2023-02-16 17:46 ESTNewsRocket Pharmaceuticals Has A Lot More UpsideN/A
2023-02-16 17:46 ESTNewsRocket Pharmaceuticals: Promising Gene Therapy Play With Discounted Entry PointN/A
2023-02-07 09:56 ESTNewsRocket rises on FDA regenerative medicine tag for cardiac gene therapyN/A
2023-01-19 22:17 ESTNewsRocket Pharmaceuticals (RCKT) Presents At 41st Annual Healthcare Conference - SlideshowN/A
2022-12-22 20:16 ESTNewsRocket Pharma to start pivotal trial for Danon Disease candidate in H1 2023N/A
2022-12-22 20:15 ESTNewsRocket defended after update on Danone Disease candidateN/A
2022-12-02 10:32 ESTNewsRenovacor (RCOR) Investor Presentation - SlideshowN/A
2022-11-29 11:43 ESTNewsRocket Pharmaceuticals: 2 Regulatory Filings In 2023 Could Propel It HigherN/A
2022-11-18 19:32 ESTNewsRocket Pharmaceuticals: Intriguing PotentialN/A
2022-11-04 07:31 ESTNewsRocket Pharmaceuticals GAAP EPS of -$0.87 misses by $0.08N/A
2022-11-02 05:56 ESTNewsRocket Pharma initiated Buy at BTIG citing gene therapy prospectsN/A
2022-10-04 05:37 ESTNewsRocket Pharmaceuticals slides over 6% after hours on $100M stock offeringN/A
2022-10-04 05:36 ESTNewsRocket Pharmaceuticals shares slide on pricing $100.3M stock offeringN/A
2022-09-30 22:18 ESTNewsRocket's gene therapy for heart disease shows promise in children/adults in phase 1 trialN/A
2022-09-20 21:22 ESTNewsRocket to acquire heart gene-therapy developer Renovacor in all-stock dealN/A
2022-08-25 17:28 ESTNewsRocket Pharmaceuticals: Updates To Thesis, Clinical Momentum Continues To AccelerateN/A
2022-08-09 07:03 ESTNewsRocket Pharmaceuticals GAAP EPS of -$0.83 misses by $0.15N/A
2022-07-09 00:41 ESTNewsRocket Pharmaceuticals an outperform at Raymond James on gene therapy programsN/A
2022-06-30 16:18 ESTNewsRocket Pharma: Poised For Growth In The Rare Disease SpaceN/A
2022-05-20 04:01 ESTNewsRocket Pharma target raised to a Street high at Stifel after latest data updateN/A
2022-05-06 06:52 ESTNewsRocket Pharmaceuticals GAAP EPS of -$0.67 beats by $0.03N/A
2022-02-24 17:54 ESTNewsRocket Pharmaceuticals GAAP EPS of -$0.69 beats by $0.04N/A
2022-01-30 12:57 ESTNewsRocket Pharmaceuticals: A Struggling Company With Long-Term UpsideN/A
2022-01-25 01:28 ESTNewsRocket Pharmaceuticals (RCKT) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2021-11-19 18:39 ESTNewsWarning: RCKT is at high risk of performing badlyN/A
2021-11-16 06:45 ESTNewsRocket Pharma crashes after plans to exclude high-dose group in Danon Disease studyN/A
2021-11-03 17:51 ESTNewsRocket Pharmaceuticals EPS misses by $0.18N/A
2021-10-20 14:23 ESTNewsRocket highlights interim data from early-stage RP-L201 pediatric disease trialN/A
2021-10-01 20:17 ESTNewsRocket Pharmaceuticals Stock Forecast: Can It Rebound To $50 Levels? A Resounding YesN/A
2021-08-30 18:10 ESTNewsRocket Pharmaceuticals receives $26.4M private placementN/A
2021-08-16 23:43 ESTNewsFDA lifts clinical hold on Rocket Pharma's Danon Disease trial of RP-A501N/A
2021-08-13 19:40 ESTNewsRocket Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-10 10:33 ESTNewsRocket Pharmaceuticals EPS beats by $0.11N/A
2021-08-10 10:31 ESTNewsRocket Pharmaceuticals, Inc. (RCKT) CEO Gaurav Shah on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-08 18:55 ESTNewsRocket Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-21 21:37 ESTNewsIs Rocket Pharmaceuticals Stock A Buy, Sell, Or Hold?N/A
2021-04-14 12:54 ESTNewsRocket Pharma announces positive outcome in early-stage trial for rare diseaseN/A
2021-03-22 12:54 ESTNewsRocket posts updated positive preliminary early-stage data from RP-L301 trialN/A
2021-03-10 18:04 ESTNewsBluebird bio upgraded to buy at Mizuho on safety updateN/A
2021-03-03 08:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $72.8 to $72.Neutral
2021-03-02 08:28 ESTAnalyst RatingThe Analyst Target Price has increased from $72.64 to $72.8.Buy
2021-02-28 04:17 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 08:21 ESTEarnings EstimateAn EPS average of -$2.57 is estimated for the 2022 year.Sell

About Rocket Pharmaceuticals, Inc (RCKT):

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has four clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia; and infantile malignant osteopetrosis, a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO Inc. The company also has a research and collaboration agreement with Lund University; and strategic collaboration agreement with Stanford University School of Medicine. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

See Advanced Chart

General

  • Name Rocket Pharmaceuticals, Inc
  • Symbol RCKT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 91
  • Last Split Factor1:4
  • Last Split Date2018-01-05
  • Fiscal Year EndDecember
  • IPO Date2015-02-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.rocketpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 7.11
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.77
  • Next Year EPS Estimate -$2.92
  • Next Quarter EPS Estimate -$0.53
  • Return on Assets -17%
  • Return on Equity -34%
  • Earnings Per Share -$1.85
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.37 billion
  • EBITDA -78589000
  • Analyst Target Price $72
  • Book Value Per Share $8.26
View More

Share Statistics

  • Shares Outstanding 61.78 million
  • Shares Float 39.48 million
  • % Held by Insiders 458%
  • % Held by Institutions 92.67%
  • Shares Short 8.25 million
  • Shares Short Prior Month 8.19 million
  • Short Ratio 17.95
  • Short % of Float 20%
  • Short % of Shares Outstanding 13%
View More

Technicals

  • Beta 1.68
  • 52 Week High $67.48
  • 52 Week Low $12.38
  • 50 Day Moving Average 56.21
  • 200 Day Moving Average 41.76
View More

Dividends

  • Dividend Date 2018-01-05
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Rocket Pharmaceuticals, Inc (RCKT) Dividend Calendar:

RCKT's last dividend payment was made to shareholders on January 5, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Rocket Pharmaceuticals, Inc (RCKT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$1.08-$0.50-114.16%
2020-09-302020-11-04$N/A-$0.53-$0.45-18.49%
2020-06-302020-08-05$N/A-$0.45-$0.5010.14%
2020-03-312020-05-08$N/A-$0.45-$0.450%
2019-12-312020-03-05$N/A-$0.39-$0.4818.26%
2019-09-302019-11-07$N/A-$0.38-$0.4821.24%
2019-06-302019-08-07$N/A-$0.38-$0.6137.7%
2019-03-312019-05-09$N/A-$0.43-$0.5318.87%
2018-12-312019-03-07$N/A-$0.66-$0.44-48.88%
2018-09-302018-11-07$N/A-$0.40-$0.449.09%
2018-06-302018-08-08$N/A-$0.40-$0.449.09%
2018-03-312018-05-11$N/A-$0.28-$0.3928.21%
2017-12-312018-03-07$N/A-$0.18-$0.3141.94%
2017-09-302017-11-08$N/A-$1.09
2017-06-302017-08-03$N/A-$0.96-$1.8848.94%
2017-03-312017-05-10$N/A-$1.60-$1.57-1.91%
2016-12-312017-03-16$N/A-$1.92-$1.73-10.98%
2016-09-302016-11-09$N/A-$1.64-$1.787.87%
2016-06-302016-08-10$N/A-$1.32-$1.5816.46%
2016-03-312016-05-11$N/A-$1.52-$0.88-72.73%
2015-12-312016-03-23$N/A-$0.52-$1.4864.86%
2015-09-302015-11-12$N/A-$2.48-$0.46-439.13%
2015-06-302015-08-06$N/A-$0.15-$0.2437.5%
2015-03-312015-05-15$N/A-$0.21-$0.3946.15%
2014-12-312015-03-16-$3.22-$0.44-631.82%

Rocket Pharmaceuticals, Inc (RCKT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Rocket Pharmaceuticals, Inc (RCKT) Chart:

Rocket Pharmaceuticals, Inc (RCKT) News:

Below you will find a list of latest news for Rocket Pharmaceuticals, Inc (RCKT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Rocket Pharmaceuticals, Inc (RCKT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-202.50.25CALL879 3612103.81TRUE-0.1-0.29
2025-06-2050.03CALL54 1155177.9FALSE-0.02-0.4
2025-06-207.50.01CALL0 550275.55FALSE00
2025-06-20100.05CALL0 293289.52FALSE00
2025-06-2012.50.05CALL0 77324.01FALSE00
2025-06-202.50.25PUT221 2828110.51FALSE-0.01-0.04
2025-06-2052.55PUT0 505191.76TRUE00
2025-06-207.55.3PUT0 2397.91TRUE00
2025-06-20100PUT0 10558.44TRUE00
2025-06-2012.50PUT0 0434.97TRUE00
2025-07-182.50.4CALL66 268108TRUE-0.23-0.37
2025-07-1850.1CALL106 1105152.85FALSE-0.05-0.33
2025-07-187.50.09CALL1 683201.33FALSE-0.02-0.18
2025-07-18100.05CALL6 1125209.66FALSE0.050
2025-07-1812.50.06CALL0 734233.33FALSE00
2025-07-18150.05CALL0 704311.15FALSE00
2025-07-1817.50.05CALL0 95240.93FALSE00
2025-07-18200.03CALL0 248419.03FALSE00
2025-07-1822.50.04CALL0 11263.91FALSE00
2025-07-18250CALL0 22273.33FALSE00
2025-07-18300CALL0 8650.53FALSE00
2025-07-182.50.45PUT2 244128.7FALSE0.010.02
2025-07-1852.5PUT0 50109.35TRUE00
2025-07-187.54.6PUT0 346223.37TRUE00
2025-07-18107.58PUT0 14261.75TRUE00
2025-07-1812.50PUT0 11397.17TRUE00
2025-07-18150PUT0 351242.59TRUE00
2025-07-1817.50PUT0 0261.07TRUE00
2025-07-18200PUT0 0349.66TRUE00
2025-07-1822.50PUT0 1364.31TRUE00
2025-07-18250PUT0 0377.39TRUE00
2025-07-18300PUT0 0400.09TRUE00
2025-10-172.50.75CALL6 164121.17TRUE-0.15-0.17
2025-10-1750.39CALL10 82145.31FALSE00
2025-10-177.50.29CALL0 182720.72FALSE00
2025-10-17100.56CALL0 3210FALSE00
2025-10-1712.50.09CALL0 118453.82FALSE00
2025-10-17150CALL0 4759.32FALSE00
2025-10-1717.50CALL0 656767.51FALSE00
2025-10-17200.1CALL0 4774.49FALSE00
2025-10-172.50.75PUT0 101116.28FALSE00
2025-10-1753.2PUT0 5109.15TRUE00
2025-10-177.50PUT0 10162.82TRUE00
2025-10-17100PUT0 313130.34TRUE00
2025-10-1712.50PUT0 11148.59TRUE00
2025-10-17150PUT0 0234.23TRUE00
2025-10-1717.50PUT0 0237.42TRUE00
2025-10-17200PUT0 0287.31TRUE00
2025-11-212.50.9CALL1 5499.89TRUE00
2025-11-2150.3CALL0 34297.98FALSE00
2025-11-217.50.5CALL0 5643.95FALSE00
2025-11-21100CALL0 239658.61FALSE00
2025-11-2112.50CALL0 2669.65FALSE00
2025-11-21150CALL0 0678.47FALSE00
2025-11-2117.50CALL0 0685.79FALSE00
2025-11-21200CALL0 2210.3FALSE00
2025-11-2122.50CALL0 2697.48FALSE00
2025-11-21250CALL0 2702.29FALSE00
2025-11-212.50.8PUT0 102132.57FALSE00
2025-11-2150PUT0 1124.82TRUE00
2025-11-217.50PUT0 2128.79TRUE00
2025-11-21107.5PUT0 37139.45TRUE00
2025-11-2112.50PUT0 0207.4TRUE00
2025-11-21150PUT0 0222.28TRUE00
2025-11-2117.50PUT0 0207.42TRUE00
2025-11-21200PUT0 0245.76TRUE00
2025-11-2122.50PUT0 0216.74TRUE00
2025-11-21250PUT0 0255.65TRUE00
2025-12-192.50.95CALL3 760129.36TRUE-0.15-0.14
2025-12-1950.56CALL0 3142172.14FALSE00
2025-12-197.50.4CALL0 273119.79FALSE00
2025-12-19100.31CALL0 579319.02FALSE00
2025-12-1912.50.35CALL1 493176.53FALSE0.350
2025-12-19150.2CALL0 261629.54FALSE00
2025-12-1917.50CALL0 2636.34FALSE00
2025-12-19200CALL0 11642.14FALSE00
2025-12-1922.50CALL0 3555.34FALSE00
2025-12-19250.05CALL0 109651.66FALSE00
2025-12-192.50.9PUT2 2515131.3FALSE0.90
2025-12-1953.01PUT0 72120.75TRUE00
2025-12-197.50PUT0 159110.49TRUE00
2025-12-19107.6PUT0 38161.94TRUE00
2025-12-1912.50PUT0 3170.28TRUE00
2025-12-19150PUT0 7193.16TRUE00
2025-12-1917.50PUT0 1229.03TRUE00
2025-12-19200PUT0 0183.97TRUE00
2025-12-1922.50PUT0 0224.71TRUE00
2025-12-19250PUT0 0249.72TRUE00
2026-01-162.51CALL17 792128.08TRUE-0.1-0.09
2026-01-1650.6CALL3 1066139.01FALSE-0.05-0.08
2026-01-167.50.54CALL0 115120.08FALSE00
2026-01-16100.4CALL0 62145.07FALSE00
2026-01-1612.50.25CALL0 228153.86FALSE00
2026-01-162.50.97PUT2 108133.84FALSE0.970
2026-01-1653PUT8 16140.34TRUE30
2026-01-167.50PUT0 0132.33TRUE00
2026-01-16107.63PUT0 1136.74TRUE00
2026-01-1612.50PUT0 0264.53TRUE00

Latest RCKT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$10.78
Jun 13, 2022 7:59 PM EST1$10.78
Jun 13, 2022 7:59 PM EST10$10.76
Jun 13, 2022 7:59 PM EST10$10.765
Jun 13, 2022 7:59 PM EST20$10.77

Rocket Pharmaceuticals, Inc (RCKT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014244/0001140361-20-014244-index.htm
2019-06-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1281895/000000000019010137/0000000000-19-010137-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009112/0000899243-18-009112-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009113/0000899243-18-009113-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009117/0000899243-18-009117-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009118/0000899243-18-009118-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009120/0000899243-18-009120-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009124/0000899243-18-009124-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009125/0000899243-18-009125-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/0000899243-18-009127-index.htm
2018-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000089924318009131/0000899243-18-009131-index.htm
2019-01-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000090266419000300/0000902664-19-000300-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000090266420000964/0000902664-20-000964-index.htm
2019-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000113777419000042/0001137774-19-000042-index.htm
2018-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036118023041/0001140361-18-023041-index.htm
2018-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118024685/0001140361-18-024685-index.htm
2018-06-25S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1281895/000114036118029781/0001140361-18-029781-index.htm
2018-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118029797/0001140361-18-029797-index.htm
2018-06-26RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118029967/0001140361-18-029967-index.htm
2018-06-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1281895/000114036118029973/0001140361-18-029973-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118030373/0001140361-18-030373-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118035455/0001140361-18-035455-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036118036347/0001140361-18-036347-index.htm
2018-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118037296/0001140361-18-037296-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036118042845/0001140361-18-042845-index.htm
2018-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118043670/0001140361-18-043670-index.htm
2018-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118043673/0001140361-18-043673-index.htm
2018-11-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036118043674/0001140361-18-043674-index.htm
2018-11-28FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118043820/0001140361-18-043820-index.htm
2018-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118044033/0001140361-18-044033-index.htm
2018-11-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036118044102/0001140361-18-044102-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118044107/0001140361-18-044107-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118044847/0001140361-18-044847-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/0001140361-18-044850-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118045226/0001140361-18-045226-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118045651/0001140361-18-045651-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036118046030/0001140361-18-046030-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036118046034/0001140361-18-046034-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002000/0001140361-19-002000-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002001/0001140361-19-002001-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002003/0001140361-19-002003-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002005/0001140361-19-002005-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002007/0001140361-19-002007-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002009/0001140361-19-002009-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002011/0001140361-19-002011-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002013/0001140361-19-002013-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002016/0001140361-19-002016-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119002021/0001140361-19-002021-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/0001140361-19-004456-index.htm
2019-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1281895/000114036119004603/0001140361-19-004603-index.htm
2019-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119007110/0001140361-19-007110-index.htm
2019-04-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119007266/0001140361-19-007266-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036119007329/0001140361-19-007329-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119007331/0001140361-19-007331-index.htm
2019-04-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281895/000114036119007333/0001140361-19-007333-index.htm
2019-04-265Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119007695/0001140361-19-007695-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1281895/000114036119008016/0001140361-19-008016-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1281895/000114036119008019/0001140361-19-008019-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119008828/0001140361-19-008828-index.htm
2019-06-17S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1281895/000114036119011159/0001140361-19-011159-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036119011272/0001140361-19-011272-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036119011273/0001140361-19-011273-index.htm
2019-06-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1281895/000114036119011328/0001140361-19-011328-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119014585/0001140361-19-014585-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036119019508/0001140361-19-019508-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119020183/0001140361-19-020183-index.htm
2019-12-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119022286/0001140361-19-022286-index.htm
2019-12-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1281895/000114036119022389/0001140361-19-022389-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036119022520/0001140361-19-022520-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120002839/0001140361-20-002839-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120003728/0001140361-20-003728-index.htm
2020-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1281895/000114036120005056/0001140361-20-005056-index.htm
2020-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120005062/0001140361-20-005062-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120006375/0001140361-20-006375-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120007081/0001140361-20-007081-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120009451/0001140361-20-009451-index.htm
2020-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120009476/0001140361-20-009476-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120009478/0001140361-20-009478-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120009709/0001140361-20-009709-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1281895/000114036120009717/0001140361-20-009717-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120010364/0001140361-20-010364-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036120011097/0001140361-20-011097-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1281895/000114036120012670/0001140361-20-012670-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120013248/0001140361-20-013248-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120013671/0001140361-20-013671-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014212/0001140361-20-014212-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014236/0001140361-20-014236-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014237/0001140361-20-014237-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014238/0001140361-20-014238-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014239/0001140361-20-014239-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014240/0001140361-20-014240-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014243/0001140361-20-014243-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120014244/0001140361-20-014244-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036120017582/0001140361-20-017582-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120017591/0001140361-20-017591-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120020136/0001140361-20-020136-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000114036120022671/0001140361-20-022671-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1281895/000114036120024856/0001140361-20-024856-index.htm
2018-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1281895/000119312518107593/0001193125-18-107593-index.htm
2018-04-13PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1281895/000119312518116946/0001193125-18-116946-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1281895/000119312518143310/0001193125-18-143310-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000119312519040836/0001193125-19-040836-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000119312520038472/0001193125-20-038472-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919119048187/0001209191-19-048187-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919119048188/0001209191-19-048188-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919119048190/0001209191-19-048190-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919119055527/0001209191-19-055527-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919119055529/0001209191-19-055529-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120008006/0001209191-20-008006-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120008012/0001209191-20-008012-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120008013/0001209191-20-008013-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120008017/0001209191-20-008017-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120008018/0001209191-20-008018-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000120919120013480/0001209191-20-013480-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000121465919001184/0001214659-19-001184-index.htm
2018-11-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281895/000149315218016873/0001493152-18-016873-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1281895/000149315219002118/0001493152-19-002118-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1281895/000149315219019095/0001493152-19-019095-index.htm
2019-12-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1281895/000149315219019176/0001493152-19-019176-index.htm
2018-07-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1281895/999999999518001714/9999999995-18-001714-index.htm
2019-06-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1281895/999999999519001425/9999999995-19-001425-index.htm
2018-12-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1281895/999999999718009309/9999999997-18-009309-index.htm
2019-05-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1281895/999999999719004162/9999999997-19-004162-index.htm

Rocket Pharmaceuticals, Inc (RCKT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rocket Pharmaceuticals, Inc (RCKT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 458%
Institutional Ownership: 9267%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-24Gaurav ShahPresident & CEOBuy90,925.000.4339,097.751,061,642.00https://www.sec.gov/Archives/edgar/data/1281895/000114036120007081/0001140361-20-007081-index.htm
2018-08-01Naveen YalamanchiDirectorSell637.0022.0014,014.00113,641.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118035455/0001140361-18-035455-index.htm
2018-12-07DAVID P SOUTHWELLDirectorSell4,923.0014.9173,401.93133,928.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/0001140361-18-044850-index.htm
2018-12-06DAVID P SOUTHWELLDirectorSell52,809.0015.15800,056.35138,851.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/0001140361-18-044850-index.htm
2018-11-27RODERICK WONGDirectorBuy967,742.0015.5015,000,001.0016,407,319.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118044107/0001140361-18-044107-index.htm
2018-12-28RODERICK WONGDirectorBuy100,000.0013.931,393,000.0016,507,319.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118046034/0001140361-18-046034-index.htm
2019-04-16RTW INVESTMENTS, LPDirectorBuy550,005.0017.509,625,087.5017,057,324.00https://www.sec.gov/Archives/edgar/data/1281895/000114036119007331/0001140361-19-007331-index.htm
2019-12-10RTW INVESTMENTS, LPDirectorBuy225,000.0022.255,006,250.0017,282,324.00https://www.sec.gov/Archives/edgar/data/1281895/000149315219019095/0001493152-19-019095-index.htm
2018-11-28DAVID P SOUTHWELLDirectorBuy153,125.00191,660.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118044850/0001140361-18-044850-index.htm
2018-04-02DAVID P SOUTHWELLDirectorBuy21,875.0038,535.00https://www.sec.gov/Archives/edgar/data/1281895/000089924318009127/0000899243-18-009127-index.htm
2018-12-20Kinnari PatelChief Operating OfficerBuy55,869.001.2167,601.4955,869.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118045651/0001140361-18-045651-index.htm
2018-12-06Kinnari PatelChief Operating OfficerBuy5,675.0014.9885,011.505,675.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118044847/0001140361-18-044847-index.htm
2020-03-18Kinnari PatelChief Operating OfficerBuy1,000.009.509,500.006,675.00https://www.sec.gov/Archives/edgar/data/1281895/000114036120006375/0001140361-20-006375-index.htm
2019-03-05Gaurav ShahOfficerSell25,000.0016.90422,500.00686,950.00https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/0001140361-19-004456-index.htm
2019-03-04Gaurav ShahOfficerSell24,900.0017.28430,272.00711,950.00https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/0001140361-19-004456-index.htm
2019-03-01Gaurav ShahOfficerSell25,000.0017.34433,500.00736,850.00https://www.sec.gov/Archives/edgar/data/1281895/000114036119004456/0001140361-19-004456-index.htm
2018-12-13DAVID P SOUTHWELLDirectorSell38,768.0015.19588,885.9295,160.00https://www.sec.gov/Archives/edgar/data/1281895/000114036118045226/0001140361-18-045226-index.htm
2020-02-25Gaurav ShahPresident & CEOBuy290,000.000.43125,628.00976,950.00https://www.sec.gov/Archives/edgar/data/1281895/000120919120013480/0001209191-20-013480-index.htm